Evidence map›Paper›PMID 35773622›Full record

ArticleBMC geriatrics2022

Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain).

Jose-Manuel Ramos-Rincon, Lidia Cobos-Palacios, Almudena López-Sampalo, Michele Ricci, Manel Rubio-Rivas, Maria-Victoria Nuñez-Rodriguez, Rodrigo Miranda-Godoy, Maria-Eugenia García-Leoni, Rosa Fernández-Madera-Martínez, Gema-María García-García and 16 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC geriatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 1 country.

Jose-Manuel Ramos-RinconDepartment of Clinical Medicine, Miguel Hernández University of Elche, Ctra N332 s/n, 03550, Sant Joan d'Alacant, Alicante, Spain. jose.ramosr@umh.es.
Lidia Cobos-PalaciosDepartment of Internal Medicine, Instituto de Investigación Biomédica de Málaga (IBIMA), Regional University Hospital of Málaga & University of Málaga, Málaga, Spain.
Almudena López-SampaloDepartment of Internal Medicine, Instituto de Investigación Biomédica de Málaga (IBIMA), Regional University Hospital of Málaga & University of Málaga, Málaga, Spain.
Michele RicciDepartment of Internal Medicine, Instituto de Investigación Biomédica de Málaga (IBIMA), Regional University Hospital of Málaga & University of Málaga, Málaga, Spain.
Manel Rubio-RivasInternal Medicine Department, Bellvitge University Hospital, , Barcelona, L'Hospitalet de Llobregat, Spain.
Maria-Victoria Nuñez-RodriguezInternal Medicine Department, Costa del Sol Hospital, Marbella, Spain.
Rodrigo Miranda-GodoyInternal Medicine Department, 12 de Octubre University Hospital, Madrid, Spain.
Maria-Eugenia García-LeoniInternal Medicine Department, Gregorio Marañon University Hospital, Madrid, Spain.
Rosa Fernández-Madera-MartínezInternal Medicine Department, Cabueñes University Hospital, Gijón, Spain.
Gema-María García-GarcíaInternal Medicine Department, Badajoz University Hospital Complex, Badajoz, Spain.
Jose-Luis Beato-PerezInternal Medicine Department, Albacete University Hospital Complex, Albacete, Spain.
Daniel Monge-MongeInternal Medicine Department, Segovia Hospital Complex, Segovia, Spain.
Uxua Asín-SamperInternal Medicine Department, Miguel Servet University Hospital, Zaragoza, Spain.
Marta Bustamante-VegaInternal Medicine Department, La Princesa University Hospital, Madrid, Spain.
Isabel Rábago-LoriteInternal Medicine Department, Infanta Sofía University Hospital, S. S. de los Reyes, Madrid, Spain.
Santiago-Jesús Freire-CastroInternal Medicine Department, A Coruña University Hospital Complex, A Coruña, Spain.
Jose-Pablo Miramontes-GonzálezInternal Medicine Department, Rio Hortega University Hospital, Valladolid, Spain.
Jeffrey-Oskar Magallanes-GamboaInternal Medicine Department, Nuestra Señora del Prado Hospital, Talavera de La Reina, Toledo, Spain.
José-Nicolás Alcalá-PedrajasInternal Medicine Department, Pozoblanco Hospital, Pozoblanco, Córdoba, Spain.
Miriam García-GómezInternal Medicine Department, Alfredo Espinosa Hospital, Urduliz, Vizcaya, Spain.
Verónica Cano-LlorenteInternal Medicine Department, Virgen de La Salud University Hospital, Toledo, Spain.
Francisco-Javier Carrasco-SánchezInternal Medicine Department, Juan Ramón Jiménez University Hospital, Huelva, Spain.
Jesús Martinez-CarrileroInternal Medicine Department, Hospital of Henares, Coslada, Madrid, Spain.
Juan-Miguel Antón-SantosInternal Medicine Department, Infanta Cristina University Hospital, Parla, Madrid, Spain.
Ricardo Gómez-HuelgasDepartment of Internal Medicine, Instituto de Investigación Biomédica de Málaga (IBIMA), Regional University Hospital of Málaga & University of Málaga, Málaga, Spain.
SEMI-COVID-19 Network
Instituto de Investigación Biomédica de Málaga · ESBellvitge University Hospital · ESCentro de Implantología Cirugía Oral y Maxilofacial · ESHospital Costa del Sol · ESHospital General De Segovia · ESHospital General Nuestra Señora del Prado · ESHospital General Universitario Gregorio Marañón · ESHospital Juan Ramón Jiménez · ESHospital Monte Naranco · ESHospital Universitario De Cabueñes · ESHospital Universitario de La Princesa · ESHospital Universitario del Henares · ESHospital Universitario Infanta Cristina · ESHospital Universitario Infanta Sofía · ESHospital Universitario Miguel Servet · ESHospital Universitario Río Hortega · ESHospital Virgen de la Salud · ESResearch Institute Hospital 12 de Octubre · ESUniversidade da Coruña · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOld age is one of the most important risk factors for severe COVID-19. Few studies have analyzed changes in the clinical characteristics and prognosis of COVID-19 among older adults before the availability of vaccines. This work analyzes differences in clinical features and mortality in unvaccinated very old adults during the first and successive COVID-19 waves in Spain.

methodsThis nationwide, multicenter, retrospective cohort study analyzes unvaccinated patients ≥ 80 years hospitalized for COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry). Patients were classified according to whether they were admitted in the first wave (March 1-June 30, 2020) or successive waves (July 1-December 31, 2020). The endpoint was all-cause in-hospital mortality, expressed as the case fatality rate (CFR).

resultsOf the 21,461 patients hospitalized with COVID-19, 5,953 (27.7%) were ≥ 80 years (mean age [IQR]: 85.6 [82.3-89.2] years). Of them, 4,545 (76.3%) were admitted during the first wave and 1,408 (23.7%) during successive waves. Patients hospitalized in successive waves were older, had a greater Charlson Comorbidity Index and dependency, less cough and fever, and met fewer severity criteria at admission (qSOFA index, PO2/FiO2 ratio, inflammatory parameters). Significant differences were observed in treatments used in the first (greater use of antimalarials, lopinavir, and macrolides) and successive waves (greater use of corticosteroids, tocilizumab and remdesivir). In-hospital complications, especially acute respiratory distress syndrome and pneumonia, were less frequent in patients hospitalized in successive waves, except for heart failure. The CFR was significantly higher in the first wave (44.1% vs. 33.3%; -10.8%; p < 0.001) and was higher among patients ≥ 95 years (54.4% vs. 38.5%; -15.9%; p < 0.001). After adjustments to the model, the probability of death was 33% lower in successive waves (OR: 0.67; 95% CI: 0.57-0.79).

conclusionsMortality declined significantly between the first and successive waves in very old unvaccinated patients hospitalized with COVID-19 in Spain. This decline could be explained by a greater availability of hospital resources and more effective treatments as the pandemic progressed, although other factors such as changes in SARS-CoV-2 virulence cannot be ruled out.

Indexed as

COVID-19AgedAged, 80 and overHospitalizationHospital MortalityHumansRegistriesRetrospective StudiesSARS-CoV-2Spain80 and overAgedComorbidityComplicationsCOVID-19EpidemiologyMorbidityMortalitySARS-CoV-2Spain

Identifiers

PMID35773622
PMCPMC9244878
OpenAlexW4283755748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.